Publications by authors named "Pierfrancesco Cirillo"

4 Publications

  • Page 1 of 1

Attitudes, Concerns, and Expectations of Consumers of Aesthetic Medicine and Surgery During the COVID-19 Outbreak: An Italian Online Survey.

Aesthet Surg J Open Forum 2020 Dec 13;2(4):ojaa037. Epub 2020 Aug 13.

As a consequence of the coronavirus disease 2019 (COVID-19) emergency, Italian physicians working in the field of aesthetic medicine and surgery considered appropriate to stop their activity in order to preserve patients' safety. This drastic measure obviously had an important impact on the medical aesthetic market causing growing concerns. To catch the current attitudes of the Italian consumers toward the aesthetic medicine and surgery, a medical advisory board devised an online survey; 216 clinicians finally participated in this survey and sent the online link through e-mail. A total of 8080/8640 (93.5%) questionnaires were returned, while 70 were removed. Approximately 49.0% ( = 3944) did not feel influenced in their desire for aesthetic treatments in spite of the pandemic emergency. Being influenced was not correlated with the uneven situation experienced on the Italian territory ( = -0.30, = 0.196); 45.4% ( = 3636) declared to be ready for rescheduling their visit, and 60.5% ( = 4844) declared that they want to allocate the same amount of resources as before. The most missed aesthetic treatment was the face (71.1% [ = 5696]). Approximately 47.0% ( = 3759) and 46.0% ( = 3679) will come back to their physician without any request or with the need for an explanation about the security protocols, respectively. Approximately 40% ( = 3314) declared that their physical appearance affects their mood fairly, 27.0% ( = 2168) strongly or very strongly, and 71.3% ( = 5708) declared physical and/or psychological decline. Looked at together, the results give us some optimistic predictions, and, therefore, the authors are confident that their patients will come back to their clinics without any particular issues. However, ensuring patient safety must be our paramount task.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1093/asjof/ojaa037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454267PMC
December 2020

Mid-face reshaping using threads with bidirectional convergent barbs: A retrospective study.

J Cosmet Dermatol 2021 Feb 28. Epub 2021 Feb 28.

Academy of Aesthetic Sciences, Naples, Italy.

Background: Minimally invasive procedures, such as thread suspension techniques, are a growing trend for facial rejuvenation. However, not enough data are available on the efficacy, outcomes, and morbidity of suture suspension techniques in mid-face reshaping.

Aims: Our goal was to assess treatment outcomes and patient satisfaction following mid-face reshaping using threads with bidirectional convergent barbs (Definisse free floating threads).

Patients/methods: We performed a retrospective analysis of 60 patients who underwent treatment for mid-face reshaping using Definisse free floating threads. Response to treatment was assessed at 6 months using the mid-face-specific Mid-Face Volume Deficit scale (Allergan ), Global Aesthetic Improvement and FACE-QTM scales.

Results: Sixty patients underwent mid-face treatment with the suspension thread technique (mean age 51.3, 90% female). No concomitant procedures were done. A reduction by one point or more in the Mid-Face Volume Deficit Scale (MDFVS) score treatment was seen in all patients after 6 months. Mean overall MFVDS and FACE-Q scores were significantly improved. On the GAIS, most patients were rated as improved or better both by the evaluating investigators and during self-assessment. No major complications were observed, and none of the patients requested the removal of the threads (mean follow-up 9.8 months, range 6-14 months).

Conclusion: Our results suggest that mid-face reshaping with Definisse free floating threads is a safe and reliable procedure characterized by low complication rates and good esthetic results. This minimally invasive procedure is a good alternative for normal or combination skin patients who refuse or want to delay the need for traditional rhytidectomy.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/jocd.14038DOI Listing
February 2021

Italian consensus report on the aesthetic use of onabotulinum toxin A.

J Cosmet Dermatol 2018 Oct 9;17(5):719-730. Epub 2018 Aug 9.

Private Practice, Milan, Italy.

Background: The aesthetic treatment of facial and neck wrinkles with botulinum toxin is constantly increasing, thus making it necessary to collect procedures guidelines for the use of botulinum toxin in the treatment of wrinkles and/or cosmetic defects.

Methods: A group of nine Italian doctors, plastic and maxillo-facial surgeons, dermatologists and aesthetic physicians, experts in face and neck aesthetic treatments with onabotulinum toxin A, discussed on procedures used in their clinical practice. From the data collected and discussed by the board, some recommendations on aesthetic treatment with onabotulinum toxin A were developed.

Results: Recommendations have been made on pretreatment, reconstitution of onabotulinum toxin A, as well as on treatment procedures, in terms of injection sites and total dose of onabotulinum toxin A for the following indications: glabellar lines, crown's feet lines, forehead lines, eyebrow shaping, lower orbicularis oculi hypertrophy, bunny lines, sagging nasal tip, gummy smile, masseter hypertrophy, perioral lines, marionette lines, hypertonic mentalis, and platysma bands.

Conclusions: The use of onabotulinum toxin A in the aesthetic field requires careful initial assessment of the patient in its complexity and individuality. Moreover, this treatment needs the use of standardized procedures to achieve the effectiveness and safety of onabotulinum toxin A in clinical practice.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/jocd.12729DOI Listing
October 2018

Safety of botulinum toxin A in aesthetic treatments: a systematic review of clinical studies.

Dermatol Surg 2014 May 28;40(5):525-36. Epub 2014 Feb 28.

Unit of Plastic Surgery, Centro Diagnostico Italiano, Milan, Italy.

Background: The use of botulinum toxin A (BoNT-A) for aesthetic treatments is growing steadily, and new safety data have been reported in recently published studies.

Objective: To investigate the safety data on the use of the three BoNT-A formulations approved for facial aesthetics from recent studies and to confirm their safety profiles.

Methods: The literature search was conducted using three online databases restricted to the timeframe from January 2000 to June 2012. Only clinical trials, randomized or open label, with safety as the primary or secondary endpoint, were included.

Results: Thirty-five papers were selected, with a total of subjects 8,787 studied. OnabotulinumtoxinA was used in 60.0% of the studies, abobotulinumtoxinA in 37.1%, and incobotulinumtoxinA in 2.8%. The glabella was the most investigated area (51.4%), followed by the upper face (25.7%), crow's feet (11.4%), and lower face (11.4%). Treatment-related adverse events were blepharoptosis (2.5%), brow ptosis (3.1%), and eye sensory disorders (3%) in the upper face and lip asymmetries and imbalances in the lower face (6.9%). All of these events resolved spontaneously.

Conclusion: The short-term safety profile of BoNT-A in cosmetic nonsurgical procedures was confirmed for all the three commercial formulations.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/dsu.12463DOI Listing
May 2014